Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Alert
Watchlist
Caplin Point Laboratories
₹1,995.20
-11.00 (0.55%) 1D
Create Stock SIPAutomate your investments in this
Performance
Open
2,019.00Prev. Close
2,006.20Volume
53,166Total traded value
10.61 CrUpper Circuit
2,394.20Lower Circuit
1,596.20Fundamentals
| Market Cap | ₹15,249Cr |
| ROE | 18.81% |
| P/E Ratio(TTM) | 26.90 |
| EPS(TTM) | 74.58 |
| P/B Ratio | 5.79 |
| Dividend Yield | 0.30% |
| Industry P/E | 34.63 |
| Book Value | 346.52 |
| Debt to Equity | 0.00 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Caplin Point Labs
Caplin Point is a fast-growing pharmaceutical company from India, developing and marketing a wide range of generic and branded medicines globally. Its core business model involves serving less competitive, unconventional markets and managing its entire supply chain from production to last-mile distribution. This strategy has enabled the company to establish over 30,000 distribution touch points in the Latin American market alone.;
| Parent Organisation | Caplin Point Laboratories Limited |
| Managing Director | Dr. Sridhar Ganesan |
| NSE Symbol | CAPLIPOINT |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 61.33 | ||
| Gland Pharma | NA (0.00%) | 42.19 | ||
| Ajanta Pharma | NA (0.00%) | 32.58 | ||
| Eris Lifesciences | NA (0.00%) | 52.95 |